早期开发能力评估的多模式框架,以加速蛋白质和抗体的发展.
Jiayin Deng1, Qiong Huang2, Jiayi Lv3
1The State Key Laboratory of Mechanism and Quality of Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, Macau 999078, China.
International journal of pharmaceutics
|February 22, 2026
概括
一个新的深度学习框架FormulationProtein准确地预测了蛋白质和抗体药物开发能力. 这种人工智能工具加速了配方开发过程,减少了昂贵的试验和错误实验,以提高药物的稳定性和安全性.
科学领域:
- 生物制药的发展.
- 计算化学是一种计算化学.
- 药物的配方 药物的配方
背景情况:
- 蛋白质和抗体疗法在现代医学中至关重要,但它们的临床成功取决于可开发性.
- 由于广泛的试验和错误实验,配方开发目前是低效和昂贵的.
- 预测可开发性需要理解蛋白质特征和配方成分之间的复杂相互作用.
研究的目的:
- 开发一种多式深度学习框架,FormulationProtein,用于准确预测蛋白质配方开发能力.
- 创建和利用四个大型数据集,涵盖结构稳定性,合稳定性,粘度和可溶性.
- 通过计算预测加速早期蛋白质和抗体的发展.
主要方法:
- 构建四个与可开发性相关的数据集,整合蛋白质和辅助剂信息.
- 开发一种多式深度学习架构 (FormulationProtein),包括蛋白质结构,序列和配方数据.
- 转移学习和传统机器学习算法的应用,用于特征表示和预测.
主要成果:
- 配方蛋白实现了高的预测准确度:形状稳定性为0.925,体稳定性为0.858,粘度为0.917,溶解性为0.742.
- 该框架成功地捕获了蛋白质属性和配方组件之间的复杂相互作用.
- 实验验证证了该框架在多种蛋白质和配方中的预测能力.
结论:
- FormulationProtein提供了一种全面的计算方法,用于早期开发能力评估.
- 这种由人工智能驱动的框架显著加速了蛋白质和抗体药物开发.
- 这项研究证明了深度学习在优化生物制药配方方面的潜力.
相关概念视频
01:25Antibody Structure and Classes
9.6K
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
9.6K
01:28Preclinical Development: Overview
6.1K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.1K
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
373
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
373